Pharmacist's Influence on Breast Cancer Patient Quality of Life (PIBC)

U

University Hospital "Sestre Milosrdnice"

Status

Completed

Conditions

Breast Cancer, Quality of Life

Treatments

Behavioral: Pharmacist's behavioral intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT02746666
1705201504032016

Details and patient eligibility

About

The purpose of this study is to investigate the impact of pharmacist behavioral intervention's influence on breast cancer patients' quality of life. Croatian randomized controlled trial. Targeted population: general population of breast cancer patients under the first adjuvant anthracycline chemotherapy. Primary outcome: difference in EORTC QLQ-BR23 questionnaire result from the baseline to after 3 week cycle.

Enrollment

70 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Early breast cancer
  • First adjuvant chemotherapy
  • Chemotherapy protocol: anthracycline x 4

Exclusion criteria

  • Cardiovascular comorbidities
  • Regular nausea or vomiting during six months before enrollment
  • Unable to answer the quality of life questionnaire on their own

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 2 patient groups

Intervention
Experimental group
Description:
Under pharmacist's behavioral intervention
Treatment:
Behavioral: Pharmacist's behavioral intervention
Control
No Intervention group
Description:
No pharmacist's behavioral intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems